| Dr Christopher John Shiepis, DO | |
|
1015 Delaware Ave Ste B, Mccomb, MS 39648-3827 | |
| (601) 250-4344 | |
| (601) 250-4345 |
| Full Name | Dr Christopher John Shiepis |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 1015 Delaware Ave Ste B, Mccomb, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992964266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 29215 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwest Ms Regional Medical Center | Mccomb, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Mississippi Regional Medical Center | 5193633907 | 65 |
| Sanford Bismarck | 9739098575 | 448 |
News Archive
A statistical analysis of publicly available heart rate data using three classification tools - Random Forests, Logistic Model Tree and Neural Network - could lead to a rapid and precise way to diagnose heart problems, according to research in the International Journal of Electronic Healthcare.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight - even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.
Charisela Technologies, Inc., a manufacturer of advanced assays for flow cytometers, announced today that it has developed an adiponectin assay with major advantages over existing technologies, including the elimination of dilutions. Adiponectin (Acrp30), an adipocytokine, is important in many therapeutic arenas, including type 2 diabetes, obesity, atherosclerosis, and rheumatoid arthritis.
A new study finds that young muskoxen conserve heat almost as well as adults, a finding that runs contrary to a longstanding assumption among scientists that young animals should be more vulnerable in extreme cold. The study, by biologist Adam Munn from the University of Sydney, Australia, will be published in the forthcoming issue of Physiological and Biochemical Zoology.
› Verified 8 days ago
| Entity Name | Southwest Mississippi Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982174488 PECOS PAC ID: 5193633907 Enrollment ID: O20080512000004 |
News Archive
A statistical analysis of publicly available heart rate data using three classification tools - Random Forests, Logistic Model Tree and Neural Network - could lead to a rapid and precise way to diagnose heart problems, according to research in the International Journal of Electronic Healthcare.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight - even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.
Charisela Technologies, Inc., a manufacturer of advanced assays for flow cytometers, announced today that it has developed an adiponectin assay with major advantages over existing technologies, including the elimination of dilutions. Adiponectin (Acrp30), an adipocytokine, is important in many therapeutic arenas, including type 2 diabetes, obesity, atherosclerosis, and rheumatoid arthritis.
A new study finds that young muskoxen conserve heat almost as well as adults, a finding that runs contrary to a longstanding assumption among scientists that young animals should be more vulnerable in extreme cold. The study, by biologist Adam Munn from the University of Sydney, Australia, will be published in the forthcoming issue of Physiological and Biochemical Zoology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher John Shiepis, DO Po Box 490, Mccomb, MS 39649-0490 Ph: (601) 250-4366 | Dr Christopher John Shiepis, DO 1015 Delaware Ave Ste B, Mccomb, MS 39648-3827 Ph: (601) 250-4344 |
News Archive
A statistical analysis of publicly available heart rate data using three classification tools - Random Forests, Logistic Model Tree and Neural Network - could lead to a rapid and precise way to diagnose heart problems, according to research in the International Journal of Electronic Healthcare.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight - even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.
Charisela Technologies, Inc., a manufacturer of advanced assays for flow cytometers, announced today that it has developed an adiponectin assay with major advantages over existing technologies, including the elimination of dilutions. Adiponectin (Acrp30), an adipocytokine, is important in many therapeutic arenas, including type 2 diabetes, obesity, atherosclerosis, and rheumatoid arthritis.
A new study finds that young muskoxen conserve heat almost as well as adults, a finding that runs contrary to a longstanding assumption among scientists that young animals should be more vulnerable in extreme cold. The study, by biologist Adam Munn from the University of Sydney, Australia, will be published in the forthcoming issue of Physiological and Biochemical Zoology.
› Verified 8 days ago
Dr. William L Duncan Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1015 Delaware Ave, Suite B, Mccomb, MS 39648 Phone: 601-250-4275 Fax: 601-249-0957 |